View Hims & Hers Health, Inc. (HIMS) current and estimated P/E ratio data provided by Seeking Alpha.

智通财经APP获悉，周三，Hims & Hers Health(HIMS.US)涨逾5%，续创历史新高，报32.23美元。消息面上，“对标卖空者香橼”的机构Hunterbrook Media周一发布 ...

1 Day HIMS -0.61% DJIA 1.18% S&P 500 1.09% Retail/Wholesale 0.75% ...

Hims and Roman are telehealth companies that sell prescription and nonprescription products to treat erectile dysfunction (ED), hair loss, and premature ejaculation (PE). Both ED and hair loss can ...

Investors in Hims & Hers Health Inc (Symbol: HIMS) saw new options begin trading today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims & Hers Health. Looking at options history for Hims & Hers Health HIMS we detected 18 trades. If we consider the ...

Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide — which sells as a weight-loss drug — is no ...

Analyst Allen Lutz of Bank of America Securities maintained a Sell rating on Hims & Hers Health (HIMS – Research Report), retaining the price target of $18.00. Discover top-rated stocks from ...

Get New Picks of the Market's Top Stocks What To Know: Market optimism surrounding Makary's selection may have bolstered Hims & Hers shares on Monday as investors anticipate that the nomination ...